You are in:Home/Publications/Prognostic Significance of Methyltransferase-Like 3 (METTL3), Procollagen-Lysine 2-Oxoglutarate 5-Dioxygenase 2 (PLOD2), and Epithelial Cadherin (E-Cadherin) Expression in Clear Cell Renal Cell Carcinoma: An Immunohistochemical study

Dr. Ebtehal Maher Abdel Aal El-sayed :: Publications:

Title:
Prognostic Significance of Methyltransferase-Like 3 (METTL3), Procollagen-Lysine 2-Oxoglutarate 5-Dioxygenase 2 (PLOD2), and Epithelial Cadherin (E-Cadherin) Expression in Clear Cell Renal Cell Carcinoma: An Immunohistochemical study
Authors: Ebtehal M. Abdel-Aal , Eman Ibrahim Elgendy, Samah I. Saleh
Year: 2026
Keywords: METTL3; PLOD2; E-Cadherin; IHC
Journal: Benha medical journal
Volume: Not Available
Issue: Not Available
Pages: Not Available
Publisher: Not Available
Local/International: Local
Paper Link: Not Available
Full paper Ebtehal Maher Abdel Aal El-sayed_8- kidney BMFJ4765811767391200.pdf
Supplementary materials Not Available
Abstract:

Background: The most prevalent type of renal cell carcinoma (RCC) is clear cell RCC (ccRCC) representing 70% of RCC. Methyltransferase-like 3 (METTL3) is critical for carcinogenesis and cancer progression. Procollagen-lysine 2-oxoglutarate 5-dioxygenase 2 (PLOD2) enhances collagen cross-linking and increases collagen stability. Epithelial Cadherin (E-cadherin) controls the actin cytoskeleton to preserve epithelial cell integrity.Aim: To demonstrate significance of METTL3, PLOD2 and E-cadherin IHC expression in ccRCC and their expressions were correlated with clinicopathological data & survival of the studied cases to find their potential prognostic role. Material and methods: This retrospective research was carried upon 50 cases of ccRCC immunohistochemically stained with METTL3, PLOD2 and E-Cadherin & the results were correlated with different clinicopathological variables and patients’ survival. Results: High METTL3 and positive E-cadherin were significantly related to younger patients’ age, small tumors < 7 cm, lower histologic grade, early tumor (T) stages, absence of regional lymph nodes and lower American Joint Committee on Cancer (AJCC) stage, better overall and progression-free survival (P

Google ScholarAcdemia.eduResearch GateLinkedinFacebookTwitterGoogle PlusYoutubeWordpressInstagramMendeleyZoteroEvernoteORCIDScopus